Synthesis of 1,3,4-Thiadiazole Derivatives and Their Anticancer Evaluation

• Published in: International journal of molecular sciences 2023-12, Vol.24 (24), p.17476
• Main Authors: Stecoza, Camelia Elena, Nitulescu, George Mihai, Draghici, Constantin, Caproiu, Miron Teodor, Hanganu, Anamaria, Olaru, Octavian Tudorel, Mihai, Dragos Paul, Bostan, Marinela, Mihaila, Mirela
• Format: Article
• Language: English
• Subjects: Apoptosis; Cancer therapies; Cell cycle; cell cycle analysis; Daphnia magna; Drug development; Drugs; Kinases; LoVo cells; MCF-7 cells; PASS prediction; Phase transitions; thiadiazole derivatives
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms242417476

Thiadiazole derivatives have garnered significant attention in the field of medicinal chemistry due to their diverse pharmacological activities, including anticancer properties. This article presents the synthesis of a series of thiadiazole derivatives and investigates their chemical characterization and potential anticancer effects on various cell lines. The results of the nuclear magnetic resonance (NMR) analyses confirmed the successful formation of the target compounds. The anticancer potential was evaluated through in silico and in vitro cell-based assays using LoVo and MCF-7 cancer lines. The assays included cell viability, proliferation, apoptosis, and cell cycle analysis to assess the compounds' effects on cancer cell growth and survival. was used as an invertebrate model for the toxicity evaluation of the compounds. The results revealed promising anticancer activity for several of the synthesized derivatives, suggesting their potential as lead compounds for further drug development. The novel compound , 5-[2-(benzenesulfonylmethyl)phenyl]-1,3,4-thiadiazol-2-amine, demonstrated good anti-proliferative effects, exhibiting an IC value of 2.44 µM against LoVo and 23.29 µM against MCF-7 after a 48-h incubation and little toxic effects in the test.